CureVac N.V. (CVAC) Financials

CVAC Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 892.0 million 254.4 million
2023-06-30 978.0 million 272.3 million
2023-03-31 937.9 million 356.7 million
2022-12-31 923.4 million 351.2 million

CVAC Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -78.3 million 1.8 million
2023-06-30 -85.2 million 3.3 million
2023-03-31 -76.0 million 3.0 million
2022-12-31 -74.9 million 2.9 million

CVAC Net Income

No data available :(

CVAC Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 495.0 million - 44.6 million
2023-06-30 590.7 million - 44.0 million
2023-03-31 545.3 million - 44.8 million
2022-12-31 536.9 million - 45.2 million

CVAC Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 237.0 million
2023-06-30 243.4 million
2023-03-31 212.5 million
2022-12-31 202.9 million

CVAC Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 14.2 million 28.8 million 16.8 million 153503
2023-06-30 15.4 million 33.6 million 20.6 million 95685
2023-03-31 22.5 million 30.1 million 25.7 million 105730
2022-12-31 22.2 million 29.6 million 25.3 million 104097

CVAC Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 17.4 million 25.7 million
2023-06-30 8.2 million 28.1 million
2023-03-31 12.7 million 87.2 million
2022-12-31 12.5 million 85.9 million

CVAC

Price: $2.33

52 week price:
2.22
12.36

Earnings Per Share: -1.59 USD

P/E Ratio: -2.18

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 537100

Market Capitalization: 517.3 million

Links: